Notably, using macrophage Colony Stimulating Factor 1 Receptor (CSF-1R) blockers reduces TAM frequency, increases IFN production, and enhances tumor cell response to drugs in pancreatic cancer models. Here, CSF1R is linked to familial pancreatic carcinoma.